Skip to main content

Lustgarten Foundation Archives

Cancer’s SOS

Mar. 28, 2019—Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.

Read more


Grant bolsters pancreatic cancer drug discovery efforts

Jan. 29, 2015—The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.

Read more


A new way to target cancer-driver Ras

Mar. 13, 2014—Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more